Genetics and Molecular Basis of Congenital Heart Defects in Down Syndrome: Role of Extracellular Matrix Regulation

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Feb 11

PMID 36769235

Authors

Nunzia Mollo

Roberta Scognamiglio

Anna Conti

Simona Paladino

Lucio Nitsch

Antonella Izzo

Affiliations

Soon will be listed here.

Abstract

Down syndrome (DS), a complex disorder that is caused by the trisomy of chromosome 21 (Hsa21), is a major cause of congenital heart defects (CHD). Interestingly, only about 50% of individuals with Hsa21 trisomy manifest CHD. Here we review the genetic basis of CHD in DS, focusing on genes that regulate extracellular matrix (ECM) organization. The overexpression of Hsa21 genes likely underlies the molecular mechanisms that contribute to CHD, even though the genes responsible for CHD could only be located in a critical region of Hsa21. A role in causing CHD has been attributed not only to protein-coding Hsa21 genes, but also to genes on other chromosomes, as well as miRNAs and lncRNAs. It is likely that the contribution of more than one gene is required, and that the overexpression of Hsa21 genes acts in combination with other genetic events, such as specific mutations or polymorphisms, amplifying their effect. Moreover, a key function in determining alterations in cardiac morphogenesis might be played by ECM. A large number of genes encoding ECM proteins are overexpressed in trisomic human fetal hearts, and many of them appear to be under the control of a Hsa21 gene, the RUNX1 transcription factor.

Citing Articles

Methyltransferase METTL3 governs the modulation of SH3BGR expression through m6A methylation modification, imparting influence on apoptosis in the context of Down syndrome-associated cardiac development.

Shi W, Chen R, Zhou M, Li Y, Zhang Y, Wang J Cell Death Discov. 2024; 10(1):396.

PMID: 39237501 PMC: 11377721. DOI: 10.1038/s41420-024-02164-3.

Characterization of the anterior segment in Trisomy 21-associated cataract using ultrasound biomicroscopy.

Shah D, Xu E, Gholap R, Sallman Z, Kolosky T, Levin M Heliyon. 2024; 10(13):e34118.

PMID: 39091934 PMC: 11292548. DOI: 10.1016/j.heliyon.2024.e34118.

Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome.

Lana-Elola E, Aoidi R, Llorian M, Gibbins D, Buechsenschuetz C, Bussi C Sci Transl Med. 2024; 16(731):eadd6883.

PMID: 38266108 PMC: 7615651. DOI: 10.1126/scitranslmed.add6883.

References

Gittenberger-de Groot A, Bartram U, Oosthoek P, Bartelings M, Hogers B, Poelmann R . Collagen type VI expression during cardiac development and in human fetuses with trisomy 21. Anat Rec A Discov Mol Cell Evol Biol. 2003; 275(2):1109-16. DOI: 10.1002/ar.a.10126. View

Korenberg J, Bradley C, Disteche C . Down syndrome: molecular mapping of the congenital heart disease and duodenal stenosis. Am J Hum Genet. 1992; 50(2):294-302. PMC: 1682442. View

Reiter T, Abraham R, Choi M, Rusnak F . Redox regulation of calcineurin in T-lymphocytes. J Biol Inorg Chem. 1999; 4(5):632-44. DOI: 10.1007/s007750050387. View

Levanon D, Groner Y . Structure and regulated expression of mammalian RUNX genes. Oncogene. 2004; 23(24):4211-9. DOI: 10.1038/sj.onc.1207670. View

Latronico M, Catalucci D, Condorelli G . MicroRNA and cardiac pathologies. Physiol Genomics. 2008; 34(3):239-42. DOI: 10.1152/physiolgenomics.90254.2008. View

Kruithof B, Krawitz S, Gaussin V . Atrioventricular valve development during late embryonic and postnatal stages involves condensation and extracellular matrix remodeling. Dev Biol. 2006; 302(1):208-17. DOI: 10.1016/j.ydbio.2006.09.024. View

Liu X, Wu H, Byrne M, Krane S, Jaenisch R . Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci U S A. 1997; 94(5):1852-6. PMC: 20006. DOI: 10.1073/pnas.94.5.1852. View

Deshpande A, Vijaya Shetty P, Frey N, Rangrez A . SRF: a seriously responsible factor in cardiac development and disease. J Biomed Sci. 2022; 29(1):38. PMC: 9185982. DOI: 10.1186/s12929-022-00820-3. View

Curran J, Makara M, Mohler P . Endosome-based protein trafficking and Ca(2+) homeostasis in the heart. Front Physiol. 2015; 6:34. PMC: 4321435. DOI: 10.3389/fphys.2015.00034. View

10.

Lyle R, Bena F, Gagos S, Gehrig C, Lopez G, Schinzel A . Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21. Eur J Hum Genet. 2008; 17(4):454-66. PMC: 2986205. DOI: 10.1038/ejhg.2008.214. View

11.

Liu Y, Huang Y, Xu C, An P, Luo Y, Jiao L . Mitochondrial Dysfunction and Therapeutic Perspectives in Cardiovascular Diseases. Int J Mol Sci. 2022; 23(24). PMC: 9788331. DOI: 10.3390/ijms232416053. View

12.

Kurnit D, Aldridge J, Matsuoka R, Matthysse S . Increased adhesiveness of trisomy 21 cells and atrioventricular canal malformations in Down syndrome: a stochastic model. Am J Med Genet. 1985; 20(2):385-99. DOI: 10.1002/ajmg.1320200222. View

13.

Aumailley M, Specks U, Timpl R . Cell adhesion to type-VI collagen. Biochem Soc Trans. 1991; 19(4):843-7. DOI: 10.1042/bst0190843. View

14.

Rahmani Z, Blouin J, Watkins P, Mattei J, POISSONNIER M, PRIEUR M . Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome. Proc Natl Acad Sci U S A. 1989; 86(15):5958-62. PMC: 297750. DOI: 10.1073/pnas.86.15.5958. View

15.

Ong S, Hausenloy D . Mitochondrial morphology and cardiovascular disease. Cardiovasc Res. 2010; 88(1):16-29. PMC: 2936127. DOI: 10.1093/cvr/cvq237. View

16.

Higashikawa A, Saito T, Ikeda T, Kamekura S, Kawamura N, Kan A . Identification of the core element responsive to runt-related transcription factor 2 in the promoter of human type X collagen gene. Arthritis Rheum. 2009; 60(1):166-78. DOI: 10.1002/art.24243. View

17.

Astrof S, Crowley D, Hynes R . Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin. Dev Biol. 2007; 311(1):11-24. PMC: 2080666. DOI: 10.1016/j.ydbio.2007.07.005. View

18.

George E, Rayburn H, Hynes R . Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development. 1993; 119(4):1079-91. DOI: 10.1242/dev.119.4.1079. View

19.

Kosaki R, Kosaki K, Matsushima K, Mitsui N, Matsumoto N, Ohashi H . Refining chromosomal region critical for Down syndrome-related heart defects with a case of cryptic 21q22.2 duplication. Congenit Anom (Kyoto). 2005; 45(2):62-4. DOI: 10.1111/j.1741-4520.2005.00065.x. View

20.

Montano M, Doughman Y, Deng H, Chaplin L, Yang J, Wang N . Mutation of the HEXIM1 gene results in defects during heart and vascular development partly through downregulation of vascular endothelial growth factor. Circ Res. 2007; 102(4):415-22. PMC: 2905161. DOI: 10.1161/CIRCRESAHA.107.157859. View